The Current State of SEP Litigation in China
China has become a major jurisdiction for resolving global standard essential patent (SEP) disputes, with its courts now open to global rate-setting, anti-suit...
We offer effective, practical experience in China.
CRA economists have a deep understanding not only of competition economics, but also of China’s culture, social and economic environment, and legislative and procedural complexities. Our experts have extensive practical experience in China, including working on both sides of the table with the Chinese antitrust agency, and testifying in antitrust and Intellectual Property litigation matters in various Chinese courts.
In our work assisting clients with China’s merger reviews and antitrust investigations, we combine global expertise and pioneering empirical and theoretical approaches with local in-depth knowledge and experience working with local regulatory agencies.
In our litigation and arbitration work in China, CRA economists are at the frontier of introducing and enhancing the use of economics analysis in antitrust and intellectual property disputes in China. We instill consistent rigor to our work, while bringing in creativity and flexibility in dealing with jurisdiction-specific issues.
Engagements
- 01CRA economists assisted TCL in its litigation against EricssonCRA economists assisted TCL in its litigation against Ericsson involving a determination of FRAND rate for cellular standard SEPs in the US and in China. The...View engagement
- 02Ingersoll Rand/Gardner DenverOn January 30, 2020, Ingersoll Rand and Gardner Denver received unconditional clearance from the European Commission with respect to the proposed combination...View engagement
- 03FRAND rate determination in multi-jurisdictional SEP litigation for OPPO against SisvelCRA economists assisted OPPO in its global litigation against Sisvel, involving FRAND rate determination for cellular standard SEPs. Dr. Fei Deng and Dr....View engagement
Meet our team
Latest Insights
Recent Events
China Law, Trade and IP 2021
Fei Deng is a panelist during the session titled “Where, When and How to Litigate in China.” For more information on this event, click here.
Toward A Deeper Understanding: 2021 Berkeley Asia IP SEP Talk Series
Dr. Fei Deng will discuss recent developments in standard essential patent (SEP) litigations and FRAND royalty rate determination in China. To register, click...